Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ZVRA stock hub

Zevra Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ZVRAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

658M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ZVRA

In the news

Latest news · ZVRA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.5

P25 12.3P50 18.4P75 33.1

Trailing P/E5.6

P25 14.9P50 23.2P75 38.5

ROE100.7

P25 -105.6P50 -46.5P75 -3.1

ROIC55.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ZVRA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001434647
Company name	Zevra Therapeutics, Inc.
Country	United States
Country code	US
Employees	61
Employees Change	2%
Employees Change Percent	3.39
Enterprise value	$458.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2015-04-16
Isin	US4884452065
Last refreshed	2026-05-10
Market cap	$658M
Market cap category	Small-Cap
Price	$11.13
Price currency	USD
Rev Per Employee	2,004,737.7x
Sector	Healthcare
Sic	2834
Symbol	ZVRA
Website	https://www.zevra.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	17.78%
EV Earnings	3.92x
EV Sales Forward	2.82x
EV/EBIT	46.03x
EV/EBITDA	36x
EV/FCF	38.22x
EV/Sales	3.75x
FCF yield	1.82%
Forward P/E	16.48x
P/B ratio	3.2x
P/E ratio	5.61x
P/S ratio	5.38x
PS Forward	4.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.15%
EBITDA Margin	10.41%
FCF margin	9.81%
Gross margin	86.07%
Gross Profit	$105.3M
Gross Profit Growth	228.91%
Gross Profit Growth Q	80.12%
Gross Profit Growth3 Y	126.71%
Gross Profit Growth5 Y	37.17%
Net Income	$117M
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Pretax Margin	109.09%
Profit Margin	101.58%
Profit Per Employee	$1.9M
Profitable Years	1
ROA	2.76
Roa5y	-11.91
ROCE	4.3
ROE	100.7
Roe5y	-48.82
ROIC	55.9
Roic5y	-123.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-20.52%
Cagr1y	48.24%
Cagr3y	31.35%
Cagr5y	3.22%
EPS Growth Quarters	5
EPS Growth Years	1
Revenue Growth	201.29x
Revenue Growth Q	77.54x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	135.42x
Revenue Growth5 Y	39.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.54
Assets	$278.6M
Cash	$200.6M
Current Assets	$230M
Current Liabilities	$47M
Debt	$1.1M
Debt EBITDA	$0.08
Debt Equity	$0.01
Debt FCF	$0.1
Equity	$205.8M
Interest Coverage	1.29
Liabilities	$72.8M
Long Term Assets	$48.6M
Long Term Liabilities	$25.7M
Net Cash	$199.5M
Net Cash By Market Cap	$30.32
Net Cash Growth	25,022.04%
Net Debt EBITDA	$-15.66
Net Debt Equity	$-0.97
Net Debt FCF	$-16.63
Tangible Book Value	$195M
Tangible Book Value Per Share	$3.3
WACC	10.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.89
Inventory Turnover	7
Net Working Capital	$-17.3M
Quick ratio	4.74
Working Capital	$182.9M
Working Capital Turnover	$1.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.19%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-89.93%
1Y total return	48.2%
200-day SMA	9.43
3Y total return	126.68%
50-day SMA	9.8
50-day SMA vs 200-day SMA	50over200
5Y total return	17.16%
All Time High	418.4
All Time High Change	-97.34%
All Time High Date	2015-08-14
All Time Low	1.94
All Time Low Change	474.9%
All Time Low Date	2020-05-21
ATR	0.54
Beta	0.88
Beta1y	0.49
Beta2y	0.73
Ch YTD	24.22
High	11.6
High52	13.16
High52 Date	2025-07-15
High52ch	-15.43%
Low	10.78
Low52	7.16
Low52 Date	2025-09-17
Low52ch	55.45%
Ma50ch	13.55%
Premarket Change Percent	0.45
Premarket Price	$11.05
Premarket Volume	1,056
Price vs 200-day SMA	18.05%
RSI	64.41
RSI Monthly	61.96
RSI Weekly	63.88
Sharpe ratio	0.89x
Sortino ratio	1.51
Total Return	-19.19%
Tr YTD	24.22
Tr1m	14.98%
Tr1w	10.53%
Tr3m	29.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	3
Analyst Price Target Top	$21.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.08
Earnings Revenue Estimate	31,840,712x
Earnings Revenue Estimate Growth	56.07x
Operating Income	$10M
Operating Income Growth5 Y	14.22
Operating margin	8.15
Price target	$23.33
Price Target Change	$110
Price Target Change Top	$94.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54,956,411%
Float Percent	92.97%
Net Borrowing	-60,092,000
Shares Insiders	1.2%
Shares Institutions	63.11%
Shares Out	59,115,084
Shares Qo Q	2.6%
Shares Yo Y	19.19%
Short Float	8.69%
Short Ratio	5.88
Short Shares	8.08

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-629,000
Average Volume	1,059,031.35x
Bv Per Share	3.48
CAPEX	$-771,000
Ch10y	-89.93
Ch1m	14.98
Ch1w	10.53
Ch1y	48.2
Ch3m	29.42
Ch3y	126.7
Ch5y	17.16
Ch6m	26.33
Change	1.18%
Change From Open	-0.09
Close	11
Days Gap	1.27
Depreciation Amortization	2,773,000
Dollar Volume	29,239,845.6
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$10M
EBITDA	$12.7M
EPS	$1.98
F Score	6
FCF	$12M
FCF EV Yield	2.62x
FCF Per Share	$0.2
Financing CF	-42,347,000
Fiscal Year End	December
Founded	2,006
Goodwill	4,701,000
Graham Number	12.46834
Graham Upside	12.02
Income Tax	$9.2M
Investing CF	87,203,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2020-12-28
Last Split Type	Reverse
Last10k Filing Date	2026-03-09
Ma150	9.4
Ma150ch	18.42%
Ma20	10.32
Ma20ch	7.84%
Net CF	58,255,000
Next Earnings Date	2026-08-11
Open	11.14
Optionable	Yes
P FCF Ratio	54.85
P OCF Ratio	51.54
Position In Range	42.68
Post Close	11.13
Postmarket Change Percent	0.63
Postmarket Price	$11.2
Ppne	1,517,000
Pre Close	11
Price Date	2026-05-08
Price EBITDA	$51.67
Ptbv Ratio	3.37
Relative Volume	2.48x
Revenue	122,289,000x
SBC By Revenue	10.32x
Share Based Comp	12,624,000
Tax By Revenue	7.51x
Tax Rate	6.88%
Tr6m	26.33%
Us State	Massachusetts
Volume	2,627,120
Z Score	3.63

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ZVRA pay a dividend?

Capital-return profile for this ticker.

Performance

ZVRA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ZVRA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+63.1%

Float: +93.0% of shares outstanding

Insider ownership

+1.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ZVRA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.4

Neutral momentum band

Price vs 200-day MA

+18.1%

50/200-day relationship not available

Beta (5Y)

0.88

Moves roughly with the market

Sharpe ratio

0.89

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ZVRA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ZVRA stock rating?

Zevra Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ZVRA analysis?

The full report lives at /stocks/ZVRA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ZVRA?

The latest report frames ZVRA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ZVRA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.